Showing 1 - 8 results of 8 for search 'Zengjun LI', query time: 0.02s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
PB2272: PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL by Lihua Qiu, Tingyu Wang, Xiuhua Sun, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu
Published 2023-08-01
Article -
8
PB2269: PI3KΔ INHIBITOR LINPERLISIB FOR ELDERLY PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL by Xiuhua Sun, Tingyu Wang, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu
Published 2023-08-01
Article